- Home
- FT vs SOPH Comparison
FT vs SOPH Comparison
Compare FT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FT
- SOPH
- Stock Information
- Founded
- FT 1988
- SOPH 2011
- Country
- FT United States
- SOPH Switzerland
- Employees
- FT N/A
- SOPH N/A
- Industry
- FT Trusts Except Educational Religious and Charitable
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FT Finance
- SOPH Health Care
- Exchange
- FT Nasdaq
- SOPH Nasdaq
- Market Cap
- FT 190.4M
- SOPH 206.6M
- IPO Year
- FT N/A
- SOPH 2021
- Fundamental
- Price
- FT $7.51
- SOPH $3.17
- Analyst Decision
- FT
- SOPH Strong Buy
- Analyst Count
- FT 0
- SOPH 2
- Target Price
- FT N/A
- SOPH $6.50
- AVG Volume (30 Days)
- FT 63.0K
- SOPH 32.6K
- Earning Date
- FT 01-01-0001
- SOPH 05-06-2025
- Dividend Yield
- FT 7.85%
- SOPH N/A
- EPS Growth
- FT N/A
- SOPH N/A
- EPS
- FT N/A
- SOPH N/A
- Revenue
- FT N/A
- SOPH $65,173,000.00
- Revenue This Year
- FT N/A
- SOPH $14.83
- Revenue Next Year
- FT N/A
- SOPH $22.79
- P/E Ratio
- FT N/A
- SOPH N/A
- Revenue Growth
- FT N/A
- SOPH 4.49
- 52 Week Low
- FT $5.97
- SOPH $2.70
- 52 Week High
- FT $7.23
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- FT 47.45
- SOPH 45.37
- Support Level
- FT $7.41
- SOPH $2.98
- Resistance Level
- FT $7.55
- SOPH $3.75
- Average True Range (ATR)
- FT 0.07
- SOPH 0.28
- MACD
- FT -0.00
- SOPH 0.03
- Stochastic Oscillator
- FT 52.63
- SOPH 24.58
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.